At a glance
ClinicalIndex Comparison RecordN/ACompleted· 48 enrolled
Drug / intervention
Text messaging plus nicotine replacement therapy +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Tobacco Treatment in the Context of Lung Cancer Screening
In Brief
A clinical study evaluating Text messaging plus nicotine replacement therapy and Standard Care at Lung Cancer Screening for Smoking Cessation. Completed, enrolled 48 participants across 1 site.
Detailed Summary
The proposed study will test a medication plus text messaging intervention specifically designed for lung cancer screening patients. Half of the patients will receive standard of care, and half will receive the treatment intervention.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartApr 2019
First PostedApr 2019
Primary CompletionOct 2023
Study CompletionFeb 2024
TodayJul 2026
First PostedApr 25, 2019
Enrollment StartApr 15, 2019
Primary CompletionOct 19, 2023
Study CompletionFeb 1, 2024
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 7.2 years ago
Interventions
Text messaging plus nicotine replacement therapybehavioral
Brief advice to quit smoking prior to lung cancer screening (LCS), 8 weeks of gain-framed, LCS-tailored text messages, and nicotine replacement therapy.
Standard Care at Lung Cancer Screeningother
Brief advice to quit smoking prior to lung cancer screening